At a glance
ClinicalIndex Comparison RecordN/ACompleted· 131 enrolled
Drug / intervention
Rad-67 Pulse oximeter & DCI Mini sensordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Noninvasive Hemoglobin Testing in Prospective Blood Donors
In Brief
A clinical study evaluating Rad-67 Pulse oximeter & DCI Mini sensor for Healthy and Anemia. Completed, enrolled 131 participants across 1 site.
Detailed Summary
The objective of this clinical investigation is to evaluate the pulse oximeter devices for screening prospective blood donors. The purpose study is to report on the accuracy of noninvasive hemoglobin (SpHb) as compared to hemoglobin measurements obtained from a laboratory hematology analyzer in a blood donation setting.
Study Details
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartJun 2020
First PostedJun 2020
Primary CompletionJul 2020
TodayJul 2026
First PostedJun 29, 2020
Enrollment StartJun 23, 2020
Primary CompletionJul 7, 2020
TodayJul 2, 2026
Enrollment to primary: 14 daysPosted 6.0 years ago
Interventions
Rad-67 Pulse oximeter & DCI Mini sensordevice
Noninvasive pulse oximeter that measures hemoglobin